A Phase 2 Study of HW211026

Clinical trial NCT07513454 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07513454
Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Actinic Keratosis

Start date: 2026-07-01
Primary completion: 2026-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.